Clinical and haematological parameters in adult AML patients: a four year experience at Nanakaly hospital for blood diseases
AbstractBackground and objectives: In adults, acute myeloid leukaemias constitute 80% of all acute leukaemia cases; its incidence progressively increases with age To define the clinical and haematological parameters of adult acute myeloid leukaemia in Erbil City. Methods: A painstaking analysis of hospital records of 94 adult patients with acute myeloid leukaemia was undertaken. The cases were diagnosed and managed at Nanakaly hospital during the years 2006-2009. Diagnosis was based on peripheral blood and marrow findings. The myeloid origin was confirmed by cytochemistry, and morphological subtyping was done according to the French-American-British (FAB) criteria. Microsoft excel version 2007 was employed for carrying out statistical analysis. Results: The studied group included 58 males and 36 females (M: F = 1.6:1). Their ages ranged between 16 and 75 years with a mean age of 33.8 years. Pallor was the commonest presenting feature (70.2%) followed by bleeding (22.3%) then fever (7.5%). The mean value of Hb was (7.6) g/dl, WBCs (34.5 x106/L), platelets (39.6 x109/L); the percentage of blast cells in peripheral blood was 42.5% and in the bone marrow was 65.9%. AML-M2 was the most frequent FAB subtype 24.4%. Conclusion: AML was commoner in males than in females (1.6:1). AML-M2 was the commonest FAB subtype. Pallor was the commonest presenting feature. Sudan black-B stain was a useful tool in the diagnosis of myeloid leukaemia .
Weinstein HJ. Acute Myeloid Leukemia. In: Pui CH, editor. Childhood Leukemias. UK: Cambridge University Press; 1999. pp. 322-35.
Bhatia S, Neglia JP. Epidemiology of childhood acute myelogenous leukemia. J Ped Oncol 1995;17:94-100
Miller KB, Daonst PR. Clinical Manifestation of Acute Myeloid Leukemia. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstiein LE, McGlave P et al, editor. Haematology Basic Principles and Practice. 5rd ed. Philadelphia: Churchill Livingstone; 2009.
Weir EG, Borowitz MJ. Flow cytometry in the diagnosis of acute leukemia. Sem Hematology 2001; 38:117-22.
Bhatia S, Ross JA, Greaves MF, Robinson LL. Epidemiology and etiology. In: Pui CH, editor. Chilhood leukemias. UK: Cambridge University Press; 1999. pp. 38-52.
Advani SH, Jussawala DJ, D Nagaraj Rao, Gangadharan P, Shetty PA. A study of 1126 leukemic cases - Epidemiologic and end-result analysis. Indian J Cancer 1979; 16:8-17.
Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K, et al. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australia and Japan adult cases. Leukemia 2000; 14:163-8.
Weinberg OK, Seetharam M, Ren L, Seo K, Ma L, Merker JD, et al. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. Blood 2009; 113 (9): 1906-8.
Ghosh S, Shinde SC, Kumaran GS, Sapre RS, Dhond SR, Badrinath Y, et al. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital 2003; 40: 1-70.
Al-Allawi N.A, Hilmi F.A, Yahya H.I, Wajdi F.T, Al-Saleem T.I, Al-Kassab F. Acute myeloid leukaemia: Morphological subtyping and haematological dindings in 214 Iraqi adults. J.Fac.Med. Baghdad 1991; 33 (1): 59-71.
Borowitz MJ, Gockerman JP, Moore JO, Civin CI, Page SO, Robertson J, et al. Clinicopathologic and cytogenetic features of CD34 (My10)- positive acute nonlymphocytic leukemia. Am J Clin Pathol 1989; 91:265-70.
Advani SH, Rao DN, Kutty PM, Gopal R, Nair CN. Acute non lymphoblastic leukemia in Indian population FAB classification and response to therapy. Ind J Cancer 1983; 20:131-6.
Advani SH, Charak BS, Banavali SD, Gopal R, Nair CN, Saikia TK, et al. Acute non-lymphoblastic leukemia in children: Prognostic factors and results of chemotherapy. Indian Pediatrics 1980; 27:14-20.
Greaves MF. Aetiology of acute leukemia. Lancet 1997; 349:344-9.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).